CD8A and neoplasm: Next, we constructed murine models and found the αKG treatment could overcome immunoevasion caused by B2M knockdown (Figure 6G), but was unable to inhibit tumor growth after CD8 depletion in vivo (Figure 6H), suggesting αKG‐induced anti‐tumor effects rely on the downstream elevated expression of B2M and CD8+ T cell functions.